<DOC>
	<DOC>NCT01232348</DOC>
	<brief_summary>The purpose of this study is to confirm the safety (ADR related to beta stimulant drugs, unexpected ADRs) and efficacy of Symbicort in daily practice and the control status on bronchial asthma and Patient satisfaction</brief_summary>
	<brief_title>Symbicort Turbuhaler 30/60 Clinical Experience Investigation</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Patients treated with Symbicort for the first time due to bronchial asthma</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>bronchial asthma</keyword>
	<keyword>Symbicort</keyword>
</DOC>